Virtu KCG Holdings’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $591K | Buy |
+70,591
| New | +$591K | 0.02% | 980 |
|
|
2017
Q1 | – | Sell |
-1,121
| Closed | -$5K | – | 3578 |
|
|
2016
Q4 | $5K | Sell |
1,121
-95
| -8% | -$424 | ﹤0.01% | 3305 |
|
|
2016
Q3 | $7K | Buy |
1,216
+182
| +18% | +$1.05K | ﹤0.01% | 2976 |
|
|
2016
Q2 | $7K | Buy |
+1,034
| New | +$7K | ﹤0.01% | 2854 |
|
|
2015
Q2 | – | Sell |
-1,378
| Closed | -$25K | – | 3106 |
|
|
2015
Q1 | $25K | Sell |
1,378
-389
| -22% | -$7.06K | ﹤0.01% | 2419 |
|
|
2014
Q4 | $33K | Buy |
+1,767
| New | +$33K | ﹤0.01% | 2615 |
|
|
2014
Q3 | – | Sell |
-1,328
| Closed | -$48K | – | 2954 |
|
|
2014
Q2 | $48K | Buy |
+1,328
| New | +$48K | ﹤0.01% | 2417 |
|